The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2003
DOI: 10.1016/s0924-8579(03)00219-x
|View full text |Cite
|
Sign up to set email alerts
|

Cyclooctadepsipeptides—an anthelmintically active class of compounds exhibiting a novel mode of action

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
39
0
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 104 publications
(41 citation statements)
references
References 40 publications
1
39
0
1
Order By: Relevance
“…One of the most recent classes of compounds, that of cyclooctadepsipeptides, has entered the scene of anthelmintic research in the early 1990s. Anthelmintically active molecules were isolated as a natural compound from the fungus Mycelia sterilia (55). The semisynthetic drug emodepside has been shown to be active against T. spiralis larvae in muscles.…”
Section: Treatment Of Trichinellosis In Humansmentioning
confidence: 99%
“…One of the most recent classes of compounds, that of cyclooctadepsipeptides, has entered the scene of anthelmintic research in the early 1990s. Anthelmintically active molecules were isolated as a natural compound from the fungus Mycelia sterilia (55). The semisynthetic drug emodepside has been shown to be active against T. spiralis larvae in muscles.…”
Section: Treatment Of Trichinellosis In Humansmentioning
confidence: 99%
“…As few new anthelmintics (that is, aminoacetylnitriles 19 and cyclooctodepsipeptides 24 ) have been discovered in the past two decades using traditional screening methods, an effective, alternative means of drug discovery is urgently needed 23 . Genome-guided drug target or drug discovery has major potential to complement conventional screening and re-purposing.…”
Section: Org)mentioning
confidence: 99%
“…At present, there appears to be no new chemical class of anthelmintics with a unique mode of action, and hence the chemical active products that are currently available are all that we are likely to have for the foreseeable future (Hennessy, 1997). One recently discovered compound, emodepside, which inhibits pharyngeal pumping of nematodes via latrophilin-like receptors (Harder et al, 2003), is very expensive and is only in use for limited animal species such as cats. Every available option should be exploited to minimise anthelmintic usage.…”
Section: Which Way Forward?mentioning
confidence: 99%